Results 1 - 20 of 4,289 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (4,077)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Age-related macular degenerationThe Lancet (British edition), 2018-09, Vol.392 (10153), p.1147-1159 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31550-2 ;PMID: 30303083Full text available |
| 2 |
Material Type: Article
|
|
The Role of Angiogenesis in Hepatocellular CarcinomaClinical cancer research, 2019-02, Vol.25 (3), p.912-920 [Peer Reviewed Journal]2018 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-1254 ;PMID: 30274981Full text available |
| 3 |
Material Type: Article
|
|
Ten years of anti-vascular endothelial growth factor therapyNature reviews. Drug discovery, 2016-06, Vol.15 (6), p.385-403 [Peer Reviewed Journal]COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Jun 2016 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2015.17 ;PMID: 26775688Full text available |
| 4 |
Material Type: Article
|
|
The immune contexture in human tumours: impact on clinical outcomeNature reviews. Cancer, 2012-04, Vol.12 (4), p.298-306 [Peer Reviewed Journal]COPYRIGHT 2012 Nature Publishing Group ;COPYRIGHT 2012 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2012 ;ISSN: 1474-175X ;EISSN: 1474-1768 ;DOI: 10.1038/nrc3245 ;PMID: 22419253Full text available |
| 5 |
Material Type: Article
|
|
Cardiovascular Toxic Effects of Targeted Cancer TherapiesThe New England journal of medicine, 2016-10, Vol.375 (15), p.1457-1467 [Peer Reviewed Journal]Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra1100265 ;PMID: 27732808Full text available |
| 6 |
Material Type: Article
|
|
Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular DiseaseHypertension (Dallas, Tex. 1979), 2018-02, Vol.71 (2), p.e1-e8 [Peer Reviewed Journal]2017 American Heart Association, Inc ;ISSN: 0194-911X ;EISSN: 1524-4563 ;DOI: 10.1161/HYPERTENSIONAHA.117.10271 ;PMID: 29279311Full text available |
| 7 |
Material Type: Article
|
|
Therapeutic targeting of the angiopoietin-TIE pathwayNature reviews. Drug discovery, 2017-09, Vol.16 (9), p.635-661 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Sep 2017 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2016.278 ;PMID: 28529319Full text available |
| 8 |
Material Type: Article
|
|
The immunology of renal cell carcinomaNature reviews. Nephrology, 2020-12, Vol.16 (12), p.721-735 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-5061 ;EISSN: 1759-507X ;DOI: 10.1038/s41581-020-0316-3 ;PMID: 32733094Full text available |
| 9 |
Material Type: Article
|
|
Tumor angiogenesis and vascular normalization: alternative therapeutic targetsAngiogenesis (London), 2017-11, Vol.20 (4), p.409-426 [Peer Reviewed Journal]Springer Science+Business Media B.V. 2017 ;Angiogenesis is a copyright of Springer, 2017. ;ISSN: 0969-6970 ;EISSN: 1573-7209 ;DOI: 10.1007/s10456-017-9562-9 ;PMID: 28660302Full text available |
| 10 |
Material Type: Article
|
|
Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug deliveryNature communications, 2018-11, Vol.9 (1), p.4433-12, Article 4433 [Peer Reviewed Journal]2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-018-06981-w ;PMID: 30401883Full text available |
| 11 |
Material Type: Article
|
|
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLCThe New England journal of medicine, 2018-06, Vol.378 (24), p.2288-2301 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1716948 ;PMID: 29863955Full text available |
| 12 |
Material Type: Article
|
|
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trialThe Lancet (British edition), 2019-10, Vol.394 (10208), p.1551-1559 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31344-3 ;PMID: 31522845Full text available |
| 13 |
Material Type: Article
|
|
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trialsThe Lancet (British edition), 2022-02, Vol.399 (10326), p.729-740 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00010-1 ;PMID: 35085502Full text available |
| 14 |
Material Type: Article
|
|
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinomaNature communications, 2016-08, Vol.7 (1), p.12624-12624, Article 12624 [Peer Reviewed Journal]Copyright Nature Publishing Group Aug 2016 ;Copyright © 2016, The Author(s) 2016 The Author(s) ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/ncomms12624 ;PMID: 27571927Full text available |
| 15 |
Material Type: Article
|
|
Targeting the HIF2-VEGF axis in renal cell carcinomaNature medicine, 2020-10, Vol.26 (10), p.1519-1530 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Springer Nature America, Inc. 2020. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-1093-z ;PMID: 33020645Full text available |
| 16 |
Material Type: Article
|
|
Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF PathwayInternational journal of molecular sciences, 2018-04, Vol.19 (4), p.1232 [Peer Reviewed Journal]2018 by the authors. 2018 ;ISSN: 1422-0067 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms19041232 ;PMID: 29670046Full text available |
| 17 |
Material Type: Article
|
|
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trialsThe Lancet (British edition), 2022-02, Vol.399 (10326), p.741-755 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00018-6 ;PMID: 35085503Full text available |
| 18 |
Material Type: Article
|
|
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degenerationBritish journal of ophthalmology, 2015-02, Vol.99 (2), p.220-226 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2014-305327 ;PMID: 25193672 ;CODEN: BJOPALFull text available |
| 19 |
Material Type: Article
|
|
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trialThe lancet oncology, 2013, Vol.14 (1), p.29-37 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(12)70477-1 ;PMID: 23168366 ;CODEN: LANCAOFull text available |
| 20 |
Material Type: Article
|
|
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trialThe Lancet (British edition), 2013-10, Vol.382 (9900), p.1258-1267 [Peer Reviewed Journal]Chakravarthy et al. Open Access article distributed under the terms of CC BY-NC-SA ;2013 Chakravarthy et al. Open Access article distributed under the terms of CC BY-NC-SA ;2014 INIST-CNRS ;Copyright © 2013 Chakravarthy et al. Open Access article distributed under the terms of CC BY-NC-SA. Published by Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 12, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)61501-9 ;PMID: 23870813 ;CODEN: LANCAOFull text available |
Results 1 - 20 of 4,289 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (4,077)
Refine My Results
Creation Date
- Before 2006 (197)
- 2006 To 2009 (908)
- 2010 To 2013 (1,252)
- 2014 To 2018 (1,461)
- After 2018 (472)
-
More options
New Records
Resource Type
- Articles (4,277)
- Book Chapters (9)
- Web Resources (1)
- magazinearticle (1)
- Books (1)
-
More options
Subject
- Vascular Endothelial Growth Factor A - Antagonists & Inhibitors (4,285)
- Science & Technology (3,885)
- Humans (3,838)
- Life Sciences & Biomedicine (3,720)
- Female (2,060)
- Male (1,943)
- Ophthalmology (1,837)
- Angiogenesis Inhibitors - Therapeutic Use (1,611)
- Bevacizumab (1,504)
- Vascular Endothelial Growth Factor (1,337)
- Aged (1,318)
- Animals (1,249)
- Middle Aged (1,204)
- Intravitreal Injections (1,197)
- Oncology (941)
- Angiogenesis Inhibitors - Administration & Dosage (873)
- Treatment Outcome (848)
- Tomography, Optical Coherence (794)
- Biological And Medical Sciences (786)
- Antibodies, Monoclonal, Humanized (786)
-
More options
Databases
- MEDLINE (4,285)
- ProQuest Central (2,566)
- GFMER Free Medical Journals (1,765)
- PubMed Central (1,497)
- DOAJ Directory of Open Access Journals (1,077)
- HighWire Press (Free Journals) (888)
- ROAD: Directory of Open Access Scholarly Resources (710)
- Springer Nature OA/Free Journals (305)
- Nature Open Access (264)
- Wiley Online Library Open Access (147)
- Medknow Open Access Medical Journals (102)
- Freely Accessible Japanese Titles (95)
- ProQuest One Psychology (94)
- IngentaConnect Free/Open Access Journals (83)
- Free E- Journals (80)
- Journals@Ovid Open Access Journal Collection Rolling (75)
- Public Library of Science (PLoS) (73)
- Taylor & Francis Open Access (59)
- Mary Ann Liebert Online - Open Access (52)
- KoreaMed Open Access (46)
-
More options
Language
Journal Title
- American Journal Of Ophthalmology (272)
- Archives Of Ophthalmology (73)
- British Journal Of Ophthalmology (196)
- Cancer Research (106)
- Eye (125)
- Graefe's Archive For Clinical And Experimental Ophthalmology (244)
- Indian Journal Of Ophthalmology (77)
- Investigative Ophthalmology & Visual Science (138)
- Ophthalmic Surgery, Lasers & Imaging (136)
- Ophthalmic Surgery, Lasers & Imaging Retina (137)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||